The International Conference on Malignant Lymphoma took place virtually and provided visitors with the latest advances in basic science, recent results of translational research, the most recent data from clinical studies and discussions about innovations in the field of lymphoma. Hematologists, clinical oncologists, radiation oncologists and the leading researchers involved in the study and treatment of lymphoid neoplasms participated in this biannual event. The following interviews were given to us on Zoom by some of the main speakers of the Conference.
The International Conference on Malignant Lymphoma took place virtually and provided visitors with the latest advances in basic science, recent results of translational research, the most recent data from clinical studies and discussions about innovations in the field of lymphoma. Hematologists, clinical oncologists, radiation oncologists and the leading researchers involved in the study and treatment of lymphoid neoplasms participated in this biannual event. The following interviews were given to us on Zoom by some of the main speakers of the Conference.
interviews
ICML 2021: vantaggi e svantaggi della modalità congressuale virtuale
I temi focali trattati a ICML 2021
Architecture of research in Lymphoma monitoring
Immune environment in the malignancy of Non-Hodgkin Lymphoma
CAR-T cells vs bispecific monoclonal antibodies in lymphoma therapy
Follicular Lymphoma: main vulnerabilities
New developments in Lymphoma radiotherapy
